John McDonough - 25 Jun 2021 Form 4 Insider Report for T2 Biosystems, Inc. (TTOO)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
29 Jun 2021, 14:56:47 UTC
Next SEC filing
02 Jul 2021
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ John Sprague, Attorney-in-fact

Key filing fact

John McDonough filed Form 4 for T2 Biosystems, Inc. (TTOO) on 29 Jun 2021.

Key facts

  • This page summarizes John McDonough's Form 4 filing for T2 Biosystems, Inc. (TTOO).
  • 3 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 29 Jun 2021, 14:56.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TTOO transaction

Common Stock

Options Exercise

Transaction value
Shares
+45,454
Change %
+9.3%
Price
Shares after
534,568
Date
25 Jun 2021
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TTOO transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-45,454
Change %
-50%
Price
$0.000000
Shares after
45,454
Date
25 Jun 2021
Ownership
Direct
Underlying class
Common Stock
Underlying amount
45,454
Exercise price
Footnotes
F1, F2
TTOO transaction Derivative

Restricted Stock Units

Award

Transaction value
$0
Shares
+81,967
Change %
Price
$0.000000
Shares after
81,967
Date
25 Jun 2021
Ownership
Direct
Underlying class
Common Stock
Underlying amount
81,967
Exercise price
Footnotes
F1, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

Footnote F2

On August 6, 2020 the reporting person was granted 45,454 restricted stock units that vested on June 25, 2021.

Footnote F3

The restricted stock units vest in one installment on the earlier of (i) June 25, 2022 and (ii) the date of the next annual meeting of stockholders.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .